TY - JOUR
T1 - Predicting functional impairment trajectories in amyotrophic lateral sclerosis
T2 - a probabilistic, multifactorial model of disease progression
AU - For the Piemonte, Valle d’Aosta Register for ALS (PARALS), for the Emilia Romagna Registry for ALS (ERRALS)
AU - Tavazzi, Erica
AU - Daberdaku, Sebastian
AU - Zandonà , Alessandro
AU - Vasta, Rosario
AU - Nefussy, Beatrice
AU - Lunetta, Christian
AU - Mora, Gabriele
AU - Mandrioli, Jessica
AU - Grisan, Enrico
AU - Tarlarini, Claudia
AU - Calvo, Andrea
AU - Moglia, Cristina
AU - Drory, Vivian
AU - Gotkine, Marc
AU - Chiò, Adriano
AU - Di Camillo, Barbara
AU - Chiò, A.
AU - Montalcini, Rita Levi
AU - Calvo, A.
AU - Moglia, C.
AU - Canosa, A.
AU - Manera, U.
AU - Vasta, R.
AU - Palumbo, F.
AU - Bombaci, A.
AU - Grassano, M.
AU - Brunetti, M.
AU - Casale, F.
AU - Fuda, G.
AU - Salomone, P.
AU - Iazzolino, B.
AU - Peotta, L.
AU - Cugnasco, P.
AU - De Marco, G.
AU - Torrieri, M. C.
AU - Gallone, S.
AU - Barberis, M.
AU - Sbaiz, L.
AU - Gentile, S.
AU - Mauro, A.
AU - Mazzini, L.
AU - Marchi, F.
AU - Corrado, L.
AU - D’Alfonso, S.
AU - Bertolotto, A.
AU - Gionco, M.
AU - Leotta, D.
AU - Oddenino, E.
AU - Cavallo, R.
AU - De Mattei, M.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/7
Y1 - 2022/7
N2 - Objective: To employ Artificial Intelligence to model, predict and simulate the amyotrophic lateral sclerosis (ALS) progression over time in terms of variable interactions, functional impairments, and survival. Methods: We employed demographic and clinical variables, including functional scores and the utilisation of support interventions, of 3940 ALS patients from four Italian and two Israeli registers to develop a new approach based on Dynamic Bayesian Networks (DBNs) that models the ALS evolution over time, in two distinct scenarios of variable availability. The method allows to simulate patients' disease trajectories and predict the probability of functional impairment and survival at different time points. Results: DBNs explicitly represent the relationships between the variables and the pathways along which they influence the disease progression. Several notable inter-dependencies were identified and validated by comparison with literature. Moreover, the implemented tool allows the assessment of the effect of different markers on the disease course, reproducing the probabilistically expected clinical progressions. The tool shows high concordance in terms of predicted and real prognosis, assessed as time to functional impairments and survival (integral of the AU-ROC in the first 36 months between 0.80–0.93 and 0.84–0.89 for the two scenarios, respectively). Conclusions: Provided only with measurements commonly collected during the first visit, our models can predict time to the loss of independence in walking, breathing, swallowing, communicating, and survival and it can be used to generate in silico patient cohorts with specific characteristics. Our tool provides a comprehensive framework to support physicians in treatment planning and clinical decision-making.
AB - Objective: To employ Artificial Intelligence to model, predict and simulate the amyotrophic lateral sclerosis (ALS) progression over time in terms of variable interactions, functional impairments, and survival. Methods: We employed demographic and clinical variables, including functional scores and the utilisation of support interventions, of 3940 ALS patients from four Italian and two Israeli registers to develop a new approach based on Dynamic Bayesian Networks (DBNs) that models the ALS evolution over time, in two distinct scenarios of variable availability. The method allows to simulate patients' disease trajectories and predict the probability of functional impairment and survival at different time points. Results: DBNs explicitly represent the relationships between the variables and the pathways along which they influence the disease progression. Several notable inter-dependencies were identified and validated by comparison with literature. Moreover, the implemented tool allows the assessment of the effect of different markers on the disease course, reproducing the probabilistically expected clinical progressions. The tool shows high concordance in terms of predicted and real prognosis, assessed as time to functional impairments and survival (integral of the AU-ROC in the first 36 months between 0.80–0.93 and 0.84–0.89 for the two scenarios, respectively). Conclusions: Provided only with measurements commonly collected during the first visit, our models can predict time to the loss of independence in walking, breathing, swallowing, communicating, and survival and it can be used to generate in silico patient cohorts with specific characteristics. Our tool provides a comprehensive framework to support physicians in treatment planning and clinical decision-making.
KW - Amyotrophic lateral sclerosis
KW - Artificial intelligence
KW - Clinical trajectories
KW - Dynamic Bayesian Networks
KW - Population model
KW - Prognosis modelling
UR - http://www.scopus.com/inward/record.url?scp=85126034303&partnerID=8YFLogxK
U2 - 10.1007/s00415-022-11022-0
DO - 10.1007/s00415-022-11022-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35266043
AN - SCOPUS:85126034303
SN - 0340-5354
VL - 269
SP - 3858
EP - 3878
JO - Journal of Neurology
JF - Journal of Neurology
IS - 7
ER -